Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?
Braz. J. Pharm. Sci. (Online); 56 (), 2020
The membrane-based efflux pump systems are recognized to have an important role in pathogenicity and drug resistance in Mycobacterium tuberculosis by the extrusion of toxic substrates and drugs from the inner bacillus. This study aimed to investigate the in vitro interaction of Verapamil (VP), an efflux ...
Verapamilo/antagonistas & inhibidores, Mycobacterium tuberculosis/aislamiento & purificación, Tuberculosis/patología, Isoniazida/agonistas, Antituberculosos, Bacillus/clasificación, Preparaciones Farmacéuticas/análisis, Resistencia a Medicamentos, Pruebas de Sensibilidad Microbiana/instrumentación, Técnicas In Vitro/métodos